1. A target lipidomics approach to investigate the acute inflammatory irritation induced by indolealkylamines from Chansu water fraction in rats
- Author
-
Jin-Ao Duan, Wuyue Chen, Jing Zhou, Liu-Qing Di, Hong-Yue Ma, Yan Gong, and Xin Yang
- Subjects
Drug ,media_common.quotation_subject ,Inflammation ,Pharmacology ,medicine.disease_cause ,Water fraction ,Drug Discovery ,Lipidomics ,medicine ,Animals ,Edema ,Adverse effect ,media_common ,business.industry ,Water ,General Medicine ,Rats ,Bufanolides ,Molecular Docking Simulation ,Complementary and alternative medicine ,Toxicity ,medicine.symptom ,Irritation ,business ,Paw edema - Abstract
Chansu has demonstrated adverse side effects in clinical settings, which is associated with its toxicity and limits its clinical applications. But there are methodological limitations of drug safety evaluation. In this study, ultra-high performance liquid chromatography, lipidomic profiling, and molecular docking were used to systemically assess Chansu-induced acute inflammatory irritation and further identify the underlying drug targets. Compared with the EtOAc extraction, Chansu water fraction comprised of indolealkylamines which caused obvious acute inflammatory irritation in rats, including acute pain (spontaneous raising foot reaction), and inflammation (paw edema). At the molecular level, lipids analysis revealed significantly higher levels of pro-inflammatory mediators of the COX and LOX pathways. However, anti-inflammatory mediators from the CYP 450, ALA, and DHA pathways were markedly decreased following exposure to the Chansu water fraction. Moreover, four indolealkylamines from Chansu showed a high theoretical affinity to a known irritation target, 5-HT2AR. These results suggest that Chansu-induced inflammatory irritation is related to the distinct dysregulation of inflammatory lipids, and peripheral 5-HT2AR is a potential target for irritation therapy. The strategy used in this study can be a crucial technology in the safety evaluation of Natural medicinal substances.
- Published
- 2021